Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $45.1450 (-0.5%) ($45.1450 - $45.1450) on Sun. Aug. 7, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.68% (three month average) | RSI | 41 | Latest Price | $45.1450(-0.5%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -1.6% a day on average for past five trading days. | Weekly Trend | HALO declines -3.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting HALO price | HALO will decline at least -1.34% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.34% (StdDev 2.68%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $40.62(-10.02%) | Resistance Level | $48.94 | 5 Day Moving Average | $46.87(-3.68%) | 10 Day Moving Average | $48.57(-7.05%) | 20 Day Moving Average | $48.94(-7.75%) | To recent high | -12.9% | To recent low | 20.8% | Market Cap | $N/A | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |